Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.

Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.

Ahmed HZ, Liu Y, O'Connell K, Ahmed MZ, Cassidy RJ, Gillespie TW, Patel P, Pillai RN, Behera M, Steuer CE, Owonikoko TK, Ramalingam SS, Curran WJ, Higgins KA.

Clin Lung Cancer. 2017 Nov;18(6):706-718. doi: 10.1016/j.cllc.2017.04.009. Epub 2017 Apr 28.

PMID:
28601387
2.

The effect of radiotherapy dose on survival in stage III non-small-cell lung cancer patients undergoing definitive chemoradiotherapy.

Koshy M, Malik R, Sher DJ, Spiotto M, Mahmood U, Aydogan B, Weichselbaum RR.

Clin Lung Cancer. 2014 Sep;15(5):365-71. doi: 10.1016/j.cllc.2014.05.004. Epub 2014 Jun 2.

PMID:
24984565
3.

Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.

Zaki M, Dominello M, Dyson G, Gadgeel S, Wozniak A, Miller S, Paximadis P.

Clin Lung Cancer. 2017 Jan;18(1):e21-e26. doi: 10.1016/j.cllc.2016.07.005. Epub 2016 Jul 22.

4.

Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database.

Vlacich G, Samson PP, Perkins SM, Roach MC, Parikh PJ, Bradley JD, Lockhart AC, Puri V, Meyers BF, Kozower B, Robinson CG.

Cancer Med. 2017 Dec;6(12):2886-2896. doi: 10.1002/cam4.1250. Epub 2017 Nov 15.

5.

Prediction of acute toxicity grade ≥ 3 in patients with locally advanced non-small-cell lung cancer receiving intensity modulated radiotherapy and concurrent low-dose Cisplatin.

Uyterlinde W, Belderbos J, Baas C, van Werkhoven E, Knegjens J, Baas P, Smit A, Rikers C, van den Heuvel M.

Clin Lung Cancer. 2013 Sep;14(5):541-8. doi: 10.1016/j.cllc.2013.04.001. Epub 2013 Jul 5.

PMID:
23835165
6.

Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401.

Takayama K, Inoue K, Tokunaga S, Matsumoto T, Oshima T, Kawasaki M, Imanaga T, Kuba M, Takeshita M, Harada T, Shioyama Y, Nakanishi Y.

Cancer Chemother Pharmacol. 2013 Dec;72(6):1353-9. doi: 10.1007/s00280-013-2335-2. Epub 2013 Oct 29.

PMID:
24166107
7.

Patterns of care for non-small cell lung cancer patients in Belgium: A population-based study.

Verleye L, De Gendt C, Vrijens F, Schillemans V, Camberlin C, Silversmit G, Stordeur S, Van Eycken E, Dubois C, Robays J, Wauters I, Van Meerbeeck JP.

Eur J Cancer Care (Engl). 2018 Jan;27(1). doi: 10.1111/ecc.12747. Epub 2017 Aug 18.

PMID:
28833865
8.

Accelerated hypofractionated radiation therapy (AHRT) for non-small-cell lung cancer: can we leave standard fractionation?

de Dios NR, Sanz X, Foro P, Membrive I, Reig A, Ortiz A, Jiménez R, Algara M.

Clin Transl Oncol. 2017 Apr;19(4):440-447. doi: 10.1007/s12094-016-1544-7. Epub 2016 Aug 23.

PMID:
27553602
9.

Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.

Yang KL, Chang YC, Ko HL, Chi MS, Wang HE, Hsu PS, Lin CC, Yeh DY, Kao SJ, Jiang JS, Chi KH.

Clin Lung Cancer. 2016 Nov;17(6):550-557. doi: 10.1016/j.cllc.2016.05.013. Epub 2016 Jun 8.

PMID:
27378175
10.

Matched-Pair Analysis of High Dose Versus Standard Dose Definitive Chemoradiation for Locally Advanced Non-Small-Cell Lung Cancer.

Johnson MD, Sura K, Mangona VS, Glick A, Wallace M, Ye H, Grills IS.

Clin Lung Cancer. 2017 Mar;18(2):149-155. doi: 10.1016/j.cllc.2016.06.004. Epub 2016 Jun 23.

PMID:
27426973
11.

Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.

Herskovic A, Mauer E, Christos P, Nagar H.

J Thorac Oncol. 2017 Feb;12(2):302-313. doi: 10.1016/j.jtho.2016.09.135. Epub 2016 Oct 14.

12.

Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.

Koshy M, Fedewa SA, Malik R, Ferguson MK, Vigneswaran WT, Feldman L, Howard A, Abdelhady K, Weichselbaum RR, Virgo KS.

J Thorac Oncol. 2013 Jul;8(7):915-22. doi: 10.1097/JTO.0b013e31828f68b4.

13.

Patterns of care in hilar node-positive (N1) non-small cell lung cancer: A missed treatment opportunity?

Bott MJ, Patel AP, Verma V, Crabtree TD, Morgensztern D, Robinson CG, Colditz GA, Waqar S, Kreisel D, Krupnick AS, Patterson GA, Broderick S, Meyers BF, Puri V.

J Thorac Cardiovasc Surg. 2016 Jun;151(6):1549-1558.e2. doi: 10.1016/j.jtcvs.2016.01.058. Epub 2016 Mar 12.

14.

Radiation Dose Escalation in Esophageal Cancer Revisited: A Contemporary Analysis of the National Cancer Data Base, 2004 to 2012.

Brower JV, Chen S, Bassetti MF, Yu M, Harari PM, Ritter MA, Baschnagel AM.

Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):985-993. doi: 10.1016/j.ijrobp.2016.08.016. Epub 2016 Aug 23.

PMID:
27869098
15.

Comparative effectiveness of aggressive thoracic radiation therapy and concurrent chemoradiation therapy in metastatic lung cancer.

Koshy M, Malik R, Mahmood U, Rusthoven CG, Sher DJ.

Pract Radiat Oncol. 2015 Nov-Dec;5(6):374-82. doi: 10.1016/j.prro.2015.07.009. Epub 2015 Aug 1.

PMID:
26412340
16.

Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBase.

Liu J, Hancock JG, Moreno AC, Wang Z, Boffa DJ, Detterbeck FC, Kim AW.

Eur J Cardiothorac Surg. 2016 Feb;49(2):596-601. doi: 10.1093/ejcts/ezv139. Epub 2015 Apr 18.

PMID:
25890936
17.

Progress in the Treatment and Outcomes for Early-Stage Non-Small Cell Lung Cancer.

Shin JY, Yoon JK, Marwaha G.

Lung. 2018 Jun;196(3):351-358. doi: 10.1007/s00408-018-0110-1. Epub 2018 Mar 17.

PMID:
29550987
18.

Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.

Kawaguchi T, Takada M, Kubo A, Matsumura A, Fukai S, Tamura A, Saito R, Maruyama Y, Kawahara M, Ignatius Ou SH.

J Thorac Oncol. 2010 May;5(5):620-30. doi: 10.1097/JTO.0b013e3181d2dcd9.

19.

Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation.

Rutter CE, Park HS, Corso CD, Yeboa DN, Mancini BR, Lester-Coll NH, Kim AW, Decker RH.

Lung Cancer. 2015 Nov;90(2):243-8. doi: 10.1016/j.lungcan.2015.08.002. Epub 2015 Aug 8.

PMID:
26277031
20.

Supplemental Content

Support Center